Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MAIA
STRONG SELLMAIA Biotechnology, Inc. · Healthcare · United States · $75M · Avg Vol: $787K/d
12
StockRankGet insider-trade alerts
Q
29
V
29
M
32
P/E (TTM)
—
ROE
-148.3%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)-1.5%
SMA 50SMA 200
Close
$1.28
RSI (14)
29.8
52W High
$3.19
From 52W High
0.4%
SCORE BREAKDOWN
Quality
29
ROIC
-631.7%0.4
ROE
-148.3%5.9
GP/Assets
—N/A
Op. Margin
0.0%41.3
FCF/Assets
-122.1%1.2
Piotroski
239.0
Int. Cover
—N/A
D/E Ratio
0.00x97.8
Current Ratio
5.59x73.9
Value
29
P/E (TTM)
—N/A
EV/EBITDA
—N/A
P/FCF
—N/A
P/B
2.7x48.6
P/S
—N/A
Div Yield
—N/A
Momentum
32
52W High %
40%15.9
RS 6M
-58%10.1
SMA 50/200
0.92x45.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+265%91.6
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$75M
P/E (Forward)
1.1x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MAIA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MAIA | MAIA Biotechnology, Inc.(you) | $75M | 12 | STRONG SELL |
| TELO | Telomir Pharmaceuticals, Inc. | $79M | 11 | STRONG SELL |
| GANX | Gain Therapeutics, Inc. | $75M | 8 | STRONG SELL |
| IMA | ImageneBio, Inc. | $63M | 11 | STRONG SELL |
| IBIO | iBio, Inc. | $71M | 9 | STRONG SELL |
| CING | Cingulate Inc. | $62M | 11 | STRONG SELL |
| ACRV | Acrivon Therapeutics, Inc. | $68M | 14 | STRONG SELL |
| MNOV | MediciNova, Inc. | $65M | 14 | STRONG SELL |
| ANVS | Annovis Bio, Inc. | $71M | 8 | STRONG SELL |
| BMEA | Biomea Fusion, Inc. | $90M | 10 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%